Literature DB >> 6640265

Cefoxitin v procaine penicillin in the treatment of uncomplicated gonorrhoea.

M Veeravahu, A H Sumathipala, J C Clay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6640265      PMCID： PMC1046248          DOI： 10.1136/sti.59.6.406

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN： 0007-134X


× No keyword cloud information.
  6 in total

1.  Screening for sexually transmissible infections in unwanted pregnancy.

Authors:  J C Clay; A F Brierley; J R Thornbury
Journal:  Br J Clin Pract       Date:  1982-02

2.  Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

Authors:  S W Berg; M E Kilpatrick; W O Harrison; J A McCutchan
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

3.  Cefoxitin in the treatment of gonorrhea.

Authors:  R B Jones; J Stimson; G W Counts; K K Holmes
Journal:  Sex Transm Dis       Date:  1979 Oct-Dec       Impact factor: 2.830

4.  Treatment of uncomplicated gonococcal urethritis with cefoxitin: comparison with penicillin.

Authors:  M S Siegel; S E Thompson; P L Perine; S T Brown; G Reynolds; C Thornsberry
Journal:  Rev Infect Dis       Date:  1979 Jan-Feb

5.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

6.  Cefoxitin vs. penicillin in the treatment of uncomplicated gonorrhea.

Authors:  W L Greaves; S J Kraus; W M McCormack; J W Biddle; A Zaidi; N J Fiumara; M E Guinan
Journal:  Sex Transm Dis       Date:  1983 Apr-Jun       Impact factor: 2.830
  6 in total
  1 in total

1.  Efficacy and Safety of Injectable and Oral Antibiotics in Treating Gonorrhea: A Systematic Review and Network Meta-Analysis.

Authors:  Jiaru Yang; Subhash Dhital; Thomas Naderer
Journal:  J Clin Med       Date:  2019-12-11       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.